[The antithrombotic jungle: an overview of the recent literature]

There is no fulltext present in this item.

Title:	[The antithrombotic jungle: an overview of the recent literature]
Author(s):	Geersing, G.J.; Greving, J.P.; Folkeringa, R.; Hemels, M.E.W. ; Cate, H. ten; Huisman, M.V.
Publication year:	2019
Source:	Nederlands Tijdschrift voor Geneeskunde, vol. 163, (2019), article D4265
ISSN:	0028-2162
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/214917
Display more details
Subject:	Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences
Organization:	Cardiology
Journal title:	Nederlands Tijdschrift voor Geneeskunde
Volume:	vol. 163
Article number:	D4265
Abstract:	Physicians encounter patients who use antithrombotics in virtually every area of medical specialisation. As antithrombotic use is often chronic, it is important for medication monitoring that physicians have sufficient knowledge of the latest developments, even if they do not prescribe antithrombotics themselves. The risk of thrombosis must be weighed against the risk of bleeding in every patient who is eligible to be treated with antithrombotics. In this article we describe the main indications for treatment with antithrombotics based on articles published within the past five years.